The RSV Vaccine Approved for Pregnant People 

padeptofruralhealth August 31, 2023

The U.S. Food and Drug Administration (FDA) approved Abrysvo, a Respiratory Syncytial Virus (RSV) vaccine, the first vaccine approved for use in pregnant individuals to prevent lower respiratory tract disease (LRTD) and severe LRTD caused by RSV in infants from birth through 6 months of age. Abrysvo is approved for use at 32 through 36 weeks gestational age of pregnancy. Abrysvo is administered as a single-dose injection into the muscle. RSV is the leading cause of infant hospitalization in the U.S. The Prescribing Information for Abrysvo includes a warning to inform that a numerical imbalance in preterm births in Abrysvo recipients (5.7%) occurred compared to those who received a placebo (4.7%). The warning informs healthcare providers that to avoid the potential risk of preterm birth with the use of Abrysvo before 32 weeks of gestation, administer Abrysvo as indicated in pregnant individuals at 32 through 36 weeks of gestational age.

The post The RSV Vaccine Approved for Pregnant People  appeared first on Pennsylvania Office of Rural Health.

Recommend0 recommendationsPublished in My Healthy Pennsylvania, Rural Health PA
Categories: My Healthy Pennsylvania, Rural Health PA
padeptofruralhealth

Related Articles

5 Essential Frameworks for Preventing Violent Child Death

The U.S. has a violent child death problem. Developing strategies to prevent violent child deaths death from firearms and traffic crashes is a demanding task that requires consideration of numerous upstream, interrelated, and tangential issues. To help safety advocates develop strategies to prevent violent child death, we compiled five frameworks to help: Understand and explain …
The post 5 Essential Frameworks for Preventing Violent Child Death appeared first on Salud America.

Network_News December 8, 2022

What Are the Risk and Protective Factors for Violent Child Death?

Gun violence and traffic crashes may seem like unpredictable events. But they are not random. They are systematic. Data reveal trends and patterns in gun violence and traffic crashes that can help us identify risk factors and protective factors. This is especially important for addressing violent child deaths. So what does the data show? Join …
The post What Are the Risk and Protective Factors for Violent Child Death? appeared first on Salud America.

Network_News October 27, 2022

How Do I Safely Use a Multi-Dose Vaccine Vial?

Many vaccines, including the current vaccines for COVID-19, come in small bottles with more than one dose inside. These are known as multiple-dose, or “multi-dose” vials, and can be used to vaccinate more than one patient. Multi-Dose Vials and Infection Control Multi-dose vials are more likely to become contaminated compared to single-dose vials, and therefore …
The post How Do I Safely Use a Multi-Dose Vaccine Vial? appeared first on Salud America.

Network_News June 14, 2022

FDA Approves New Drug for Alzheimer’s, But Scientists Divided Over Decision

The U.S. Food and Drug Administration approved a new drug called Aduhelm (aducanumab) to treat Alzheimer’s disease, the most common form of dementia. Many are applauding the drug and are encouraged by the scientific progress in a field that has long had limited treatment options. Alzheimer’s affects over 6.2 million people in the U.S., with …
The post FDA Approves New Drug for Alzheimer’s, But Scientists Divided Over Decision appeared first on Salud America.

Network_News June 15, 2021
0 Comments

The RSV Vaccine Approved for Pregnant People 

padeptofruralhealth August 31, 2023

The U.S. Food and Drug Administration (FDA) approved Abrysvo, a Respiratory Syncytial Virus (RSV) vaccine, the first vaccine approved for use in pregnant individuals to prevent lower respiratory tract disease (LRTD) and severe LRTD caused by RSV in infants from birth through 6 months of age. Abrysvo is approved for use at 32 through 36 weeks gestational age of pregnancy. Abrysvo is administered as a single-dose injection into the muscle. RSV is the leading cause of infant hospitalization in the U.S. The Prescribing Information for Abrysvo includes a warning to inform that a numerical imbalance in preterm births in Abrysvo recipients (5.7%) occurred compared to those who received a placebo (4.7%). The warning informs healthcare providers that to avoid the potential risk of preterm birth with the use of Abrysvo before 32 weeks of gestation, administer Abrysvo as indicated in pregnant individuals at 32 through 36 weeks of gestational age.

The post The RSV Vaccine Approved for Pregnant People  appeared first on Pennsylvania Office of Rural Health.

Recommend0 recommendationsPublished in My Healthy Pennsylvania, Rural Health PA
Categories: My Healthy Pennsylvania, Rural Health PA
padeptofruralhealth

Related Articles

5 Essential Frameworks for Preventing Violent Child Death

The U.S. has a violent child death problem. Developing strategies to prevent violent child deaths death from firearms and traffic crashes is a demanding task that requires consideration of numerous upstream, interrelated, and tangential issues. To help safety advocates develop strategies to prevent violent child death, we compiled five frameworks to help: Understand and explain …
The post 5 Essential Frameworks for Preventing Violent Child Death appeared first on Salud America.

Network_News December 8, 2022

What Are the Risk and Protective Factors for Violent Child Death?

Gun violence and traffic crashes may seem like unpredictable events. But they are not random. They are systematic. Data reveal trends and patterns in gun violence and traffic crashes that can help us identify risk factors and protective factors. This is especially important for addressing violent child deaths. So what does the data show? Join …
The post What Are the Risk and Protective Factors for Violent Child Death? appeared first on Salud America.

Network_News October 27, 2022

How Do I Safely Use a Multi-Dose Vaccine Vial?

Many vaccines, including the current vaccines for COVID-19, come in small bottles with more than one dose inside. These are known as multiple-dose, or “multi-dose” vials, and can be used to vaccinate more than one patient. Multi-Dose Vials and Infection Control Multi-dose vials are more likely to become contaminated compared to single-dose vials, and therefore …
The post How Do I Safely Use a Multi-Dose Vaccine Vial? appeared first on Salud America.

Network_News June 14, 2022

FDA Approves New Drug for Alzheimer’s, But Scientists Divided Over Decision

The U.S. Food and Drug Administration approved a new drug called Aduhelm (aducanumab) to treat Alzheimer’s disease, the most common form of dementia. Many are applauding the drug and are encouraged by the scientific progress in a field that has long had limited treatment options. Alzheimer’s affects over 6.2 million people in the U.S., with …
The post FDA Approves New Drug for Alzheimer’s, But Scientists Divided Over Decision appeared first on Salud America.

Network_News June 15, 2021
0 Comments

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Invite this member to groups
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .